glp-1 drugs sleep apnea Survey: Providers Want GLP-1s Approved for Certain Patients Benefit Most from

When used in conjunction with diet and exercise, it can cause significant weight loss and a reduced risk of cancer, diabetes and heart disease in people who are obese or overweight

Your provider may slow dose escalation or maintain a lower dose if you experience persistent gastrointestinal symptoms

In fact, many people who experience mild gastrointestinal adjustment go on to achieve significant weight loss results

In immature animals, IGF1 can activate the brain-gonadal axis and contributes to the timing of puberty in males and females by affecting GnRH neurons and possibly kisspeptin neurons in the hypothalamus [18]

In this review, we discuss the mechanistic and clinical synergies that make the combined use of GLP-1RAs and SGLT2is appealing in patients with T2DM